CS logo
small CS logo
RCMed

Sochaczew, Poland
Medical center in Sochaczew
aleja 600-lecia 45, 96-500 Sochaczew

About RCMed


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
R-Pharm International, LLC
2
EMD Serono Research & Development Institute, Inc.
1
Galapagos NV
1
Gedeon Richter Plc.
1
IBSA Institut Biochimique SA
1
Integrative Research Laboratories AB
1
Pfizer
1
Sandoz
1
Total Rows: 8

Clinical Trials at RCMed


During the past decade, RCMed conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11223300110011110000001100221111Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA
2015-09-24
2019-09-06
Completed
210
Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis
2016-03-31
2017-09-26
Completed
353
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
2016-05-24
2019-11-05
Completed
1,648
Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
2017-07-04
2021-09-01
Completed
2,106
A Study to Evaluate the Clinical Performance and Safety of an Intra-articular Hyaluronic Acid in Knee Osteoarthritis
2017-06-29
2018-10-30
Completed
692
Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis
2017-09-18
2019-09-23
Completed
390
Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis
2019-05-28
2024-10-01
Active, not recruiting
109
Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis
2021-09-21
2023-11-15
Active, not recruiting
473

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "RCMed" #1 sponsor was "R-Pharm International, LLC" with 2 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Gedeon Richter Plc." with 1 trials sponsored and "IBSA Institut Biochimique SA" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "RCMed" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsR-Pharm International, LLC: 2R-Pharm International, LLC: 2EMD Serono Research &Development Institute,Inc.: 1EMD Serono Research &Development Institute,Inc.: 1Galapagos NV: 1Galapagos NV: 1Gedeon Richter Plc.: 1Gedeon Richter Plc.: 1IBSA Institut Biochimique SA: 1IBSA Institut Biochimique SA: 1Integrative ResearchLaboratories AB: 1Integrative ResearchLaboratories AB: 1Pfizer: 1Pfizer: 1Sandoz: 1Sandoz: 1

Created with Highcharts 11.1.0Top CollaboratorsOCT Clinical Trials: 2OCT Clinical Trials: 2Gilead Sciences: 1Gilead Sciences: 1Hexal AG: 1Hexal AG: 1IQVIA Pvt. Ltd: 1IQVIA Pvt. Ltd: 1Merck KGaA,Darmstadt, Germany: 1Merck KGaA,Darmstadt, Germany: 1Quintiles, Inc.: 1Quintiles, Inc.: 1

Clinical Trials Conditions at RCMed


According to Clinical.Site data, the most researched conditions in "RCMed" are "Rheumatoid Arthritis" (5 trials), "Ankylosing Spondylitis" (1 trials), "Knee Osteoarthritis" (1 trials), "Non-Radiographical Axial Spondyloarthritis" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "RCMed" in a lesser frequency.

Clinical Trials Intervention Types at RCMed


Most popular intervention types in "RCMed" are "Drug" (6 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Adalimumab - GP2017" (1 trials), "Adalimumab - US licensed Humira" (1 trials), "Adalimumab 40mg q2w" (1 trials) and "Concomitant treatment" (1 trials). Other intervention names were less common.

Clinical Trials Genders at RCMed


The vast majority of trials in "RCMed" are 7 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at RCMed


Currently, there are NaN active trials in "RCMed". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in RCMed, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in RCMed, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 2: 3Phase 2: 3Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Active, not recruiting: 2Active, not recruiting: 2Recruiting: 1Recruiting: 1